We use cookies to provide you with the best possible experience. By using Orbitax's services, you agree that we may store cookies on your device. Cookie Policy.
The AI assistant for tax questions
Track worldwide tax law changes daily
Cross-border tax analysis and data
Unify and empower your entity management
Provides compliance steps, forms & rates
Visualize and manage your entity data
Comprehensive compliance management
Audit and global tax controversy tracking
Manage reportable cross-border arrangements
Country-by-country reporting & compliance
Pillar 2 planning, reporting and compliance
Calculate US tax impact of foreign operations
Automated workflows for recurring tax tasks
Secure API connections to 3rd-party systems
Secure storage for your tax documentation
The AI assistant for tax questions
Collaborate securely on your tax data
Share This Article
|
|
The Financial Oversight and Management Board for Puerto Rico (Oversight Board) sent a letter to United States (US) President Trump asking for Puerto Rico to play “a leading role” in the increased manufacture of American pharmaceuticals. The Oversight Board’s message was prompted by public dialogue about potential policy changes that would redirect the manufacturing of pharmaceutical and medical products to the United States.According to the Oversight Board, Puerto Rico is a major center for pharmaceutical and medical device manufacturing, as “8% of pharmaceutical expenditures by Americans are for products manufactured in Puerto Rico.” The Oversight Board said the Puerto Rico...